
Changhwa J. Cheu
Examiner (ID: 6970)
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1677, 1641 |
| Total Applications | 1728 |
| Issued Applications | 1108 |
| Pending Applications | 178 |
| Abandoned Applications | 490 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19113950
[patent_doc_number] => 20240125700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR)
[patent_app_type] => utility
[patent_app_number] => 17/769253
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769253 | SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR) | Oct 13, 2020 | Pending |
Array
(
[id] => 19113950
[patent_doc_number] => 20240125700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR)
[patent_app_type] => utility
[patent_app_number] => 17/769253
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769253 | SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR) | Oct 13, 2020 | Pending |
Array
(
[id] => 16599359
[patent_doc_number] => 20210025890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => METHODS FOR DETECTING AND QUANTIFYING FGF21
[patent_app_type] => utility
[patent_app_number] => 17/063640
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063640 | METHODS FOR DETECTING AND QUANTIFYING FGF21 | Oct 4, 2020 | Abandoned |
Array
(
[id] => 18022046
[patent_doc_number] => 20220373545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON SYSTEMIC LUPUS ERYTHEMATOSUS
[patent_app_type] => utility
[patent_app_number] => 17/765640
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765640 | BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON SYSTEMIC LUPUS ERYTHEMATOSUS | Sep 28, 2020 | Pending |
Array
(
[id] => 16576609
[patent_doc_number] => 20210011010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS FOR SOLID TUMOR DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 17/035607
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035607 | APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS FOR SOLID TUMOR DIAGNOSIS | Sep 27, 2020 | Abandoned |
Array
(
[id] => 20303431
[patent_doc_number] => 12449416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Identification of health status in the elderly using immunological biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/763572
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 3303
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763572 | Identification of health status in the elderly using immunological biomarkers | Sep 22, 2020 | Issued |
Array
(
[id] => 17991311
[patent_doc_number] => 20220357348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHOD FOR DETERMINING POTENCY OF THERAPEUTIC ANTI-CLEVER-1 ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/762489
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762489 | METHOD FOR DETERMINING POTENCY OF THERAPEUTIC ANTI-CLEVER-1 ANTIBODY | Sep 22, 2020 | Pending |
Array
(
[id] => 17475001
[patent_doc_number] => 20220082505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => Rapid Methanol Detection Device
[patent_app_type] => utility
[patent_app_number] => 17/024620
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024620 | Rapid Methanol Detection Device | Sep 16, 2020 | Abandoned |
Array
(
[id] => 16542333
[patent_doc_number] => 20200408747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => DIGITAL IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 17/021235
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021235 | DIGITAL IMMUNOASSAY | Sep 14, 2020 | Abandoned |
Array
(
[id] => 17931112
[patent_doc_number] => 20220326237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => MEANS TO DETECT WHETHER ACUTE HEPATOPANCREATIC NECROSIS DISEASE-CAUSING VIBRIO PARAHAEMOLYTICUS IS VIRULENT OR NON-VIRULENT
[patent_app_type] => utility
[patent_app_number] => 17/641402
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641402 | Means to detect whether acute hepatopancreatic necrosis disease-causing vibrio parahaemolyticus is virulent or non-virulent | Sep 9, 2020 | Issued |
Array
(
[id] => 17931112
[patent_doc_number] => 20220326237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => MEANS TO DETECT WHETHER ACUTE HEPATOPANCREATIC NECROSIS DISEASE-CAUSING VIBRIO PARAHAEMOLYTICUS IS VIRULENT OR NON-VIRULENT
[patent_app_type] => utility
[patent_app_number] => 17/641402
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641402 | Means to detect whether acute hepatopancreatic necrosis disease-causing vibrio parahaemolyticus is virulent or non-virulent | Sep 9, 2020 | Issued |
Array
(
[id] => 17914733
[patent_doc_number] => 20220317128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHOD FOR DETECTING PARTICULATE SUBSTANCE USING IMMUNOCHROMATOGRAPHY, AND KIT FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/640032
[patent_app_country] => US
[patent_app_date] => 2020-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640032 | METHOD FOR DETECTING PARTICULATE SUBSTANCE USING IMMUNOCHROMATOGRAPHY, AND KIT FOR SAME | Sep 6, 2020 | Pending |
Array
(
[id] => 18568322
[patent_doc_number] => 20230258658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Assay for Assessing Heart Failure
[patent_app_type] => utility
[patent_app_number] => 17/640819
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640819 | Assay for Assessing Heart Failure | Sep 2, 2020 | Abandoned |
Array
(
[id] => 20257130
[patent_doc_number] => 12429477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Methods and agents for determining patient status
[patent_app_type] => utility
[patent_app_number] => 17/639815
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 26749
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639815 | Methods and agents for determining patient status | Sep 2, 2020 | Issued |
Array
(
[id] => 17898399
[patent_doc_number] => 20220308061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHOD TO SEQUENCE MRNA IN SINGLE CELLS IN PARALLEL WITH QUANTIFICATION OF INTRACELLULAR PHENOTYPE
[patent_app_type] => utility
[patent_app_number] => 17/638092
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638092 | METHOD TO SEQUENCE MRNA IN SINGLE CELLS IN PARALLEL WITH QUANTIFICATION OF INTRACELLULAR PHENOTYPE | Sep 1, 2020 | Pending |
Array
(
[id] => 16886764
[patent_doc_number] => 20210172960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING
[patent_app_type] => utility
[patent_app_number] => 17/000102
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17000102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/000102 | COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING | Aug 20, 2020 | Abandoned |
Array
(
[id] => 17414379
[patent_doc_number] => 20220049283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Method of detecting SARS-CoV-2 cleavage targeted proprotein convertase and facilitated protease activity
[patent_app_type] => utility
[patent_app_number] => 16/947760
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947760 | Method of detecting SARS-CoV-2 cleavage targeted proprotein convertase and facilitated protease activity | Aug 13, 2020 | Abandoned |
Array
(
[id] => 16658667
[patent_doc_number] => 20210055304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => METHOD FOR THE DETECTION OF A BINDING PARTNER OF A MULTISPECIFIC BINDER
[patent_app_type] => utility
[patent_app_number] => 16/945730
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/945730 | METHOD FOR THE DETECTION OF A BINDING PARTNER OF A MULTISPECIFIC BINDER | Jul 30, 2020 | Abandoned |
Array
(
[id] => 17838956
[patent_doc_number] => 20220276261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => C3/C5 CONVERTASE ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/631561
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631561 | C3/C5 CONVERTASE ASSAYS | Jul 30, 2020 | Pending |
Array
(
[id] => 16871511
[patent_doc_number] => 20210164978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/943912
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16943912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/943912 | Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies | Jul 29, 2020 | Issued |